Tappet

← Back to Tappet
Conshohocken feed of tappet.org
Education · Nov 19, 2026

Bioadvance - Vittoria Biotherapeutics Announces FDA RMAT and Orphan Drug Designations for Senza5 CART5 (VIPER-101) in T-Cell Lym

https://bioadvance.com/vittoria-biotherapeutics-announces-fda-rmat-and-orphan-drug-designations-for-senza5-cart5-viper-101-in-t-cell-lymphoma/?utm_source=rss&utm_medium=rss&utm_campaign=vittoria-biotherapeutics-announces-fda-rmat-and-orphan-drug-designations-for-senza5-cart5-viper-101-in-t-cell-lymphoma

Join the conversation on Tappet